Improving Sleep, Fatigue, Activity & Quality of Life in Cancer Survivors Via a Transdiagnostic Intervention
Launched by UNIVERSITY OF OKLAHOMA · Jun 13, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is looking at a new program designed to help cancer survivors improve their sleep, reduce tiredness during the day, increase physical activity, and enhance overall quality of life. Many cancer survivors have trouble sleeping well, which can affect their energy and daily functioning. Unlike traditional treatments that focus only on serious sleep disorders, this program takes a broader approach by teaching healthy sleep habits, relaxation techniques, and ways to manage energy. The program is delivered through six weekly one-on-one sessions over Zoom, making it easy to join from home.
Adults who have finished their main cancer treatment at least six months ago and who have some mild to moderate sleep difficulties might be eligible to join. Participants should be able to use a smartphone or computer with internet access and be comfortable speaking and reading English. Those with severe mental health issues, recent substance abuse, or currently getting other sleep treatments won’t qualify. During the study, participants will complete surveys and wear a device that tracks their activity to see if the program helps improve their sleep and daily well-being. This small pilot study with 10 participants aims to see if the program is practical and helpful, paving the way for larger studies in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥18 years old
- • ≤7 on RU-SATED questionnaire
- • ≥6 months removed from primary cancer treatment
- • able to speak/read English
- • can sign informed consent
- • have internet access via smartphone or computer
- Exclusion Criteria:
- • ≥15 on Patent Health Questionnaire 8
- • ≥10 on Generalized Anxiety Disorder-7
- • self-reported current or recent history (≤2 years) of drug or alcohol abuse
- • history of nervous system disorder \[e.g., stroke, Parkinson's disease, multiple sclerosis\]
- • severe mental illness such as schizophrenia or bipolar disorder
- • current or recent history (≤5 years) of shift work
- • currently receiving a sleep intervention
About University Of Oklahoma
The University of Oklahoma, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials and research initiatives. With a robust network of interdisciplinary experts and state-of-the-art facilities, the university fosters an environment that promotes scientific discovery and the development of new treatments. Its commitment to patient-centered research ensures that clinical trials not only adhere to the highest ethical standards but also aim to address pressing health challenges. By collaborating with various stakeholders, including industry partners and healthcare providers, the University of Oklahoma seeks to translate research findings into tangible benefits for communities, ultimately enhancing the quality of care and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oklahoma City, Oklahoma, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported